← Open Payments lookup

MICHAEL LANG: Open Payments

NPI 1205203155 · NEW MILFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,157 in 56 payments from 23 companies in 2025. Trend: 2023 $64 · 2024 $2,641 · 2025 $1,157

Food & beverage: $1,157
CompanyPaymentsAmount
TAIHO ONCOLOGY, INC.6$126
Karyopharm Therapeutics Inc.1$124
Merck Sharp & Dohme LLC5$112
Janssen Biotech, Inc.7$109
Astellas Pharma US Inc4$82
Bayer Healthcare Pharmaceuticals Inc.3$69
GlaxoSmithKline, LLC.3$62
AstraZeneca Pharmaceuticals LP3$57
Eisai Inc.3$54
ABBVIE INC.3$54

Products named: LONSURF, XPOVIO, KEYTRUDA, Vyloy, TECVAYLI, Lenvima, ELAHERE, OPDIVO.

Industry payments across NJ — which companies pay providers there.